Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01663
|
|||||
Drug Name |
Fucoxanthin
|
|||||
Synonyms |
Fucoxanthin; UNII-06O0TC0VSM; CCRIS 4055; all-trans-Fucoxanthin; BRN 0073179; 06O0TC0VSM; beta,beta-Carotene, 3'-(acetyloxy)-6',7'-didehydro-5,6-epoxy-5,5',6,6',7,8-hexahydro-3,5'-dihydroxy-8-oxo-, (3S,3'S,5R,5'R,6S,6'R)-; (3S,5R,6S,3'S,5'R,6'R)-3,5'-dihydroxy-8-oxo-6',7'-didehydro-5,6-epoxy-5,6,7,8,5',6'-hexahydro-beta,beta-caroten-3'-yl acetate; (3'S,5'R,6'R)-3'-acetoxy-5,6-epoxy-3,5'-dihydroxy-6',7'-didehydro-5,6,7,8,5',6'-hexahydro-beta,beta-caroten-8-one
|
|||||
Indication | Metabolic syndrome [ICD11: 5A40-5A4Z] | Phase 2 | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C42H58O6
|
|||||
Canonical SMILES |
CC(=CC=CC=C(C)C=CC=C(C)C(=O)CC12C(CC(CC1(O2)C)O)(C)C)C=CC=C(C)C=C=C3C(CC(CC3(C)O)OC(=O)C)(C)C
|
|||||
InChI |
InChI=1S/C42H58O6/c1-29(18-14-19-31(3)22-23-37-38(6,7)26-35(47-33(5)43)27-40(37,10)46)16-12-13-17-30(2)20-15-21-32(4)36(45)28-42-39(8,9)24-34(44)25-41(42,11)48-42/h12-22,34-35,44,46H,24-28H2,1-11H3/b13-12+,18-14+,20-15+,29-16+,30-17+,31-19+,32-21+/t23?,34-,35-,40+,41+,42-/m0/s1
|
|||||
InChIKey |
SJWWTRQNNRNTPU-ABBNZJFMSA-N
|
|||||
CAS Number |
CAS 3351-86-8
|
|||||
Pharmaceutical Properties | Molecular Weight | 658.9 | Topological Polar Surface Area | 96.4 | ||
Heavy Atom Count | 48 | Rotatable Bond Count | 12 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | |||
XLogP |
8.1
|
|||||
PubChem CID | ||||||
ChEBI ID |
CHEBI:5186
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | ClinicalTrials.gov (NCT03613740) Effect of Fucoxanthin on the Components of the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion | |||||
2 | Carotenoids reverse multidrug resistance in cancer cells by interfering with ABC-transporters. Phytomedicine. 2012 Aug 15;19(11):977-87. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.